Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Corbus Pharmaceuticals Q4 EPS $(2.61) Misses $(2.10) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(2.61) per share which missed the analyst consensus estimate of $(2.10) by 24.29 percent. This is a 8.75 percent decrease over losses of $(2.40) per
byBenzinga Newsdesk
March 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(2.61) per share which missed the analyst consensus estimate of $(2.10) by 24.29 percent. This is a 8.75 percent decrease over losses of $(2.40) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts